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Abstrak
UNAIDS data 2018 menunjukkan 36,9 juta orang hidup dengan HIV, 4400 kasus di 
antara orang dewasa (berusia diatas 15 tahun lebih), hampir 43% wanita. Kira-kira 24% 
kematian pada wanita hamil atau pasca melahirkan dikaitkan dengan HIV di Sub Sahara 
Afrika. Kehamilan dan pasca melahirkan adalah waktu risiko HIV yang persisten dan 
memiliki risiko kematian yang lebih besar sehingga diperlukan perhatian yang khusus 
pada ibu hamil yang terinfeksi HIV. Tujuan penelitian ini untuk mengetahui pengalaman 
kehamilan pada wanita yang terinfeksi HIV. Mengidentifikasi PubMed dan Proquest dari 
tahun 2015-2018,  dengan memasukkan kata kunci “pregnant HIV” OR “pregnancy HIV” 
OR “HIV pregnant” OR “HIV pregnancy” AND experience*. Kriteria inklusi dan ekslusinya 
ditentukan menggunakan: kerangka Populasi, Exposure, Outcome dan Study (PEOS) 
Design, PRISMA flow diagram, ekstraksi data dan CASP dan pemetaan hasil temuan. Dari 
378 artikel diseleksi kemudian didapatkan 7 artikel dengan design kualitatif mengemukakan 
tentang pengungkapan status HIV yang masih disembunyikan karena ketidakberanian, 
kekerasan dan stigma di masyarakat. Kurangnya dukungan tenaga kesehatan dalam 
memberikan informasi dan asuhan kehamilan tentang HIV dapat mengurangi kepatuhan 
ART. Dukungan dari keluarga dan teman sebaya dapat mencegah penularan HIV ke bayi. 
Wanita hamil yang positif HIV memiliki harapan agar kehamilannya sehat dan bayinya 
terbebas dari HIV. Pengungkapan status HIV masih menjadi ketakutan dan kekhawatiran. 
Akan tetapi dukungan yang positif dari orang terdekat, masyarakat maupun dari tenaga 
kesehatan yang terlibat dapat memotivasi ibu hamil dengan HIV untuk meningkatkan 
kesehatannya.
Kata Kunci: HIV, Kehamilan HIV, Pengalaman HIV 
Abstract
The 2018 UNAIDS data showed that 36.9 million people live with HIV. Of these, 4,400 
cases found among adults (> 15 years old) and nearly 43% were women. In Sub-Saharan 
Africa, it was estimated that 24% of maternal deaths during prenatal or postnatal care were 
associated with HIV. Therefore, clinical attention is highly required during pregnancy and 
after delivery, particularly for those who are infected or at greater risk of HIV. This study 
aimed to determine pregnancy experience among women with HIV. PubMed and Proquest 
were used to search relevant articles from 2015-2018 by typing the keywords: “pregnant 
HIV” OR “pregnancy HIV” OR “HIV pregnant” OR “HIV pregnancy” AND “experience”. The 
inclusion and exclusion criteria was determined through: Population, Exposure, Outcome 
and Study Design (PEOS) framework, PRISMA flow diagram, data extraction and CASP, 
and mapping the findings. Of 378 selected articles, 7 articles were found to be relevant 
with the study objective. Using qualitative designs, the articles discussed the disclosure of 
HIV status that remained hidden. This was due to lack of courage, high level of violence, 
negative stigma in community and lack of support from health practitioners in providing 
information about HIV during pregnancy. Support from family and peers can prevent HIV 
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transmission from pregnant women to their fetus. Pregnant women with HIV can still 
expect that their pregnancy will be healthy and no HIV transmission to their newborn. 
Disclosure of HIV status remains be fear and concern. However, positive support from 
family, community and health practitioners can motivate pregnant women with HIV to 
improve their health.
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INTRODUCTION
According to the data UNAIDS 2018 showed 
36.9 million people are living with HIV, about 
5.000 cases per day are new cases in adults 
and children. About 66% of cases are in Sub 
Saharan Africa (SSA). Five hundred cases under 
the age of 15 years and around 4.400 cases over 
the age of 15 years, nearly 43% were women, 
33% of young children (15–24 years) and about 
19% of young women (15–24 years). East and 
South Africa are still ranked first for the number 
of adults and children living with HIV as many as 
19.600.000 cases and as many as 800.000 new 
cases of HIV infection (1). In data Indonesia 2018 
showed 46,659 cases of people living with HIV 
positive. Of 1,805,993 pregnant tested for HIV, 
there were 5,074 (0.28%) pregnant who tested 
positive for HIV (2)  
HIV and pregnancy-related complications 
are the two main causes of global death for 
women of reproductive age (3). HIV-infected 
women have a high risk of worsening the 
condition of pregnancy and the postpartum 
period (4). Pregnant with HIV will increase 
about eight times higher mortality than pregnant 
who are not infected with HIV. Based on these 
estimates, approximately 24% of deaths occur in 
pregnant or postpartum women associated with 
HIV in SSA (5). 
Despite the expansion of quality Prevention 
of Mother-to-Child Transmission of HIV (PMTCT) 
services and widespread use of Option B+ 
(Antiretroviral Therapy/ART), most countries 
in sub-Saharan Africa have not yet reached 
the UNAIDS target for pregnant and postnatal 
(6). Pregnant who are infected with HIV need 
adequate prophylactic steps from prenatal, 
childbirth and post-natal care so that they require 
greater attention among health professionals 
(7)of which 187 infants were exposed and 
uninfected, 19 seroconverted, and 12 were still 
inconclusive in July 2015. Therefore, the overall 
vertical HIV transmission rate in the period was 
8.7%. Most (71.6%. 
Pregnancy experience is different for 
everyone, through this period is believed to be a 
motivation for women infected with HIV as a belief 
that the role of motherhood is stronger so that 
it requires support from the people involved so 
that the burden of HIV becomes lighter (8). The 
purpose of this review literature is to summarize 
the findings of pregnancy experiences in women 
infected with HIV. 
MATERIALS AND METHODS
The article is searched through the PubMed 
and Proquest database, entering terms according 
to purpose, using the Boolean operator to 
combine the same performing keywords for the 
two “pregnant HIV” OR “pregnancy HIV “HIV 
pregnant” OR “HIV pregnancy” AND experience* 
databases. inclusion at the time of the search 
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was free full-text, data published in 2015 - 2018 
and in English amounted to 378 articles.The 
inclusion and exclusion criteria used Population, 
Exposure, Outcome and Study Design (PEOS), 
whose population was all women who had 
been pregnant positively HIV, the result is the 
experience of pregnancy with a design study that 
is relevant to the experience of pregnancy in HIV. 
RESULTS AND DISCUSSION
Based on the results of the literature review, 
one study explained that 85,7% of women 
were infected with HIV through unprotected 
(unprotected) sexual relations with men  (10). 
The seven articles reviewed were mostly done 
in East Africa (4 articles), South Africa (1 article), 
the United States of America (1 article) and the 
United Kingdom (1 article). The major themes 
gained in the experience of pregnant women 
with HIV are 1) Disclosure of HIV status, 2) 
Fig. 1 PRISMA Flow Chart
Pregnancy support and care for HIV women, 
and 3) Pregnancy expectations for HIV women.
Disclosure of HIV Status
Almost all participants conceal their HIV status 
from professional staff as well as partners/family 
and friends. Lack of disclosure about HIV status due 
to lack of courage and stigma, especially diaspora 
in the African community, domestic violence, 
poor relations and fears of being abandoned by 
a partner (11–13,16) and discrimination in society 
(13,15,16) if they reveal HIV status. Throughout 
pregnancy and breastfeeding participants are 
haunted by a fear of death before revealing their 
status, some participants experience rejection by a 
partner especially if the partner is tested negative 
(12), however, it is different for women who have 
revealed their HIV status to their family, especially 
to their partners, they get support especially in 
treatment (11,14).
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Table 1 . Extraction Data
No Title/Autor/Year/Country Country Research Type Result  
1. Facilitators and barriers 
to uptake and adherence 
to lifelong antiretroviral 
therapy among HIV 
infected pregnant women 
in Uganda: a qualitative 
study/Buregyeya et 
al/2017
Urganda, 
East Africa 
Qualitative study
In-depth 
interviews with 57 
HIV women
a. Stigma, fear of being seen with antiretroviral drugs, 
fear of being abandoned and violence by partners, 
length of treatment and side effects, lack of health 
workers in providing IEC and HIV-related care are 
barriers to lifelong HIV treatment adherence.
b. Support of spouse / family and peers.
c. The hopes and desires of mothers to have healthy 
children and want to live longer
2. ‘I wanted to safeguard 
the baby’: a qualitative 
study to understand the 
experiences of Option B+ 
for pregnant women and 
the potential implications 
for ‘test-and-treat’ in four 
sub-Saharan African 
settings/ McLean et 
al/2016
Malawi, 
Tanzania and 
Uganda, 
East Africa
Qualitative study
In-depth 
interviews with 22 
HIV women and 
15 health workers 
a. The lack of support and services of Ante Natal 
Care (ANC) further impedes the ability especially 
in young mothers who are first pregnant
b. There is still a hierarchy of power and little two-
way communication because of the rush of health 
workers
3. “Out of All of this Mess, 
I Got a Blessing”: 
Perceptions and 
Experiences of 
Reproduction and 
Motherhood in African 
American Women Living 
With HIV/Fletcher et 
al/2016
South 
Carolina  
south United 
States
Qualitative study
In-depth 
interviews with 42 
HIV women
a. Expectations in pregnancy and the role of 
motherhood through changes in health behavior 
to minimize the risk of transmission to the baby
b. Support service providers in offering good advice 
and respecting patient autonomy when counseling 
HIV-infected women.
4. Perceptions and 
decision-making with 
regard to pregnancy 
among HIV positive 
women in rural Maputo 
Province, Mozambique 
- a qualitative study/
Cuinhane et al/2018
Mozambique, 
East Africa
A Qualitative 
study of a 
grounded 
theory approach 
semi-structure 
interviews and 
FGDs with 59 HIV 
women and health 
nurses
a. Stigma, discrimination and fear will be left by the 
couple
b. Pregnancy with HIV is a disease that will spread 
to babies
c. Need support from the husband for treatment, 
support for health workers for counseling and 
therapy, especially ART adherence during 
pregnancy and breastfeeding
d. Women do not have the power to make decisions 
about pregnancy
e. Barriers to adherence to treatment are related to 
transport costs and side effects of ART
5. Psychosocial challenges 
facing women living with 
HIV during the perinatal 
period in rural Uganda/
Ashaba et al/2017
Urganda, 
East Africa 
Qualitative studi
Semi-structured 
interviews with 20 
HIV women
a. Disclosure of HIV status, gender inequality, stigma 
and discrimination, get negative treatment by 
health workers every time they visit the hospital
b. There is no support from partners and often gets 
violence, economic hardships so as to prevent 
and interfere with their ability to follow HIV-related 
treatment and care
6. The lived experiences of 
rural women diagnosed 
with the human 
immunodeficiency virus 
in the antenatal period/
Fords et al/2017
South Africa Qualitative 
study of 
phenomenological 
approach semi-
structured 
interviews with 10 
HIV women
a. Stigma, cruelty by partners, and isolation during 
pregnancy and breastfeeding
b. Support, and the role of mothers give them 
enthusiasm for treatment compliance and provide 
hope for their children free of HIV
7. ‘We have beaten HIV a 
bit’: a qualitative study 
of experiences of peer 
support during pregnancy 
with an HIV Mentor 
Mother project in England/
McLeish and Redshaw 
/2016
England Qualitative study
In-depth and 
semi structured 
interviews with 12 
HIV women 
a. Stigma, fear and isolation but they have the desire 
to protect their families from HIV
b. Difficult to access information and antenatal care 
by health workers because health workers do not 
have much time to provide comprehensive care
c. Peer support programs (mother mentors) and 
mothers provide strength during pregnancy and 
make a good impact by strengthening medical 
advice to avoid mother-to-child HIV transmission.
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Disclosure of HIV status contributes 
to reducing HIV transmission to infants by 
increasing treatment compliance among HIV 
pregnant. Research in Nigeria suggests treatment 
adherence is 2,3 times greater for those who have 
revealed HIV status (17) and the importance of 
partner involvement during pregnancy (18). 
Research conducted by Ramlagan (2018) 
found a strong positive relationship between 
male partner involvement during pregnancy 
and disclosure of HIV status (18) to increase 
adherence to the use of HAART is consistent 
with research conducted by Odiachi (2018) in 
rural Nigeria (19). In another study, 79,5% of 
women had revealed their status, but were still 
limited to fathers or a small number of family (20), 
the results they receive are generally positive 
and support what is experienced (21)emotional 
adjustment to the disease, and reduced risk of 
HIV transmission, but women face both real and 
perceived barriers to disclosure. We examined 
patterns and predictors of HIV disclosure in a 
cohort of 200 women diagnosed or confirmed to 
have HIV during antenatal care in the Kilimanjaro 
region of Tanzania and followed participants 
to three months postpartum. Twenty women 
also completed qualitative in-depth interviews 
during pregnancy and three months postpartum. 
During the pregnancy period (at least 30 days 
post-diagnosis. In some women, they are more 
comfortable expressing with peers because they 
have a sense of trust, care and empathy (22). 
Support and Antenatal Care in HIV-Positive 
Women
In several studies it was reported that 
there was no support from a husband or partner 
and family in treatment (11–14,16), such as a 
prohibition by a husband to take HIV drugs (14). 
and inadequate economic, preventing them 
from taking medication (13). Lack of support 
from health practitioners in providing health 
education and counseling especially pregnancy 
care and knowledge about HIV is a barrier to their 
adherence to treatment (11), and officers do not 
have much time to care about the anxiety that 
pregnant experience (15). Lacking social support 
causes them to tend to avoid and withdraw (23). 
Participants consider pregnancy with HIV to be a 
dangerous disease and can cause death which 
will add to their concern if transmitting HIV to 
their baby (12,13,15,16).
Basically support from partners, family 
and peers, support from organizations, groups 
and service personnel was reported to be able 
to improve adherence to the use of ART in 
pregnant women (10–12,14,15)little is known about 
reproductive decision-making processes for African 
American women living with HIV. The overall goal of 
our study was to qualitatively explore perspectives 
related to reproduction and motherhood in HIV-
infected African American women of childbearing 
capacity. HIV-infected African American women 
of childbearing capacity in South Carolina 
(N = 42, research in Malawi suggests that support 
contributes greatly to the treatment of Option B + 
(24)”container-title”:”Journal of Acquired Immune 
Deficiency Syndromes (1999. Peer support is very 
important and has a positive impact on preventing 
HIV transmission to infants and improving the 
health of mothers and children, helping women 
in solving problems, there is a sense of caring 
and empathic like the Mother Mentor Project in 
the UK (15) and Mother Support Group (MSG) in 
Zimbabwe (25). 
In accordance with WHO guidelines, HIV-
positive pregnant are required to take ART 
regardless of their lifetime CD4 cell count to 
prevent transmission to their babies (Option B+), 
but there are some women who do not comply 
with treatment for various reasons. Through an 
integrated family and Antenatal Care approach 
it has proven effective in improving services and 
programs for the Prevention of Mother-to-Child 
Transmission of HIV (PMTCT) (26). In line with 
the policy strategy undertaken by Ethiopia to 
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expand PMTCT services and increase treatment 
coverage by utilizing antenatal care visits (27). 
HIV-positive women generally have better 
knowledge (28) because they are motivated to 
make themselves healthier in the hope of not 
wanting to spread HIV to their babies. Several 
studies have shown the reasons pregnant  do 
not adhere to treatment, including stigma, fear 
of embarrassment seen with ART, fear of being 
abandoned by partners and domestic violence, 
forgetfulness, large tablet size, long treatment, 
side effects of ART, living in the countryside and 
the cost of transport high because they have to 
take drugs far away (11,16). In other studies, 
long distance, low household income and living 
in a rural environment are significant factors 
associated with compliance with low utilization 
of PMTCT services (17). Ethiopia through 
its strategy by increasing household welfare 
through economic empowerment for women and 
increasing access to services in particular paying 
more attention to rural areas (27).
Some pregnant adhere to treatment during 
pregnancy and breastfeeding, but leave treatment 
after the weaning period (16), busy taking care of 
the baby and other responsibilities or maybe loss or 
death to the baby (11). Some participants who did 
not disclose their HIV status to partners managed 
to follow ART treatment during pregnancy (16), they 
are motivated because treatment gives them hope 
of having a baby who will be born HIV negative 
(10–15). Disclosure of HIV status is significantly 
associated with improving treatment adherence, 
especially in HIV-positive pregnant women such 
as research in Nigeria (17), however, attitudes 
differ from studies in Saudi Arabia, more than 40% 
of them suggest that people living with HIV are 
negative and should be isolated (23).
Expectations of pregnancy in HIV positive 
women
According to their pregnancy experience 
with HIV, the hope for pregnancy at that time was 
to have a healthy baby free from HIV infection. 
this is the main motivation for women to start 
ART, they want to stay healthy and live longer 
so they can care for children (11), so have the 
chance to become parents (12) and fulfill her role 
as a mother (10), strengthening spiritual beliefs 
through prayer and accepting the situation of 
those infected with HIV HIV (10,15). However, 
experience in some women, they are often afraid 
due to deteriorating health and the possibility of 
HIV transmission to infants, women think that 
pregnancy with HIV is a disease that can cause 
death (16).
At present, HIV pregnant women can 
have high hopes for their pregnancy, through 
the Option B+ PMTCT program with few side 
effects (29) in the United States, they were 
infected with HIV through PMTCT programs do 
care continuum from pregnancy to postpartum 
and provide excellent results in the long-term 
health, about half of HIV-positive women do 
99% of vaginal delivery infants were tested for 
HIV result is (30) and research in Iran shows 
that if HIV-positive pregnant women to follow the 
PMTCT program, they can realistically expect 
to give birth to uninfected children (31) This is 
consistent with the expectations of all women 
to live longer with their children through healthy 
changes in behavior patterns and adherence 
to treatment according to the PMTCT program. 
CONCLUSION AND RECOMMENDATION
Experience an HIV-positive mother ’s 
pregnancy is different from the disclosure of HIV 
status, support and health services received, 
and the expectation of pregnancy in women 
who are HIV positive which is a separate 
obstacle in pregnant women. Disclosure of status 
may be different for each woman, disclosure 
of HIV status is still a stigma, fear, anxiety, 
discrimination, sometimes they have to cover 
HIV status in order to comply with treatment. 
However, a good and positive support of the 
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partner / family, peers, community to pregnant 
mothers are able to provide reinforcement to 
adhere to the treatment that aims to stay healthy 
and avoid transmission to the baby. Professional 
officers who are involved in caring for pregnant 
women continuously motivate making it easier 
for pregnant women to access information, 
strengthen and expand counseling through 
knowledge, especially HIV in pregnancy and 
increasing coverage of treatment and expanding 
access to prevent transmission to infants.
The confidence and adherence of pregnant to 
treatment through the role of motherhood can 
prevent transmission of HIV to their babies and 
wishes to care for children in accordance with 
the expectations of all pregnant women.
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